The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound
Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Akira Nishiyama

Department of Pharmacology

Kagawa University Medical School




Name/email consistency: high



  • Department of Pharmacology, Kagawa University Medical School, Kagawa, Japan. 2003 - 2011
  • Department of Physiology, Tulane University School of Medicine, New Orleans, Louisiana, USA. 2002 - 2006


  1. Urinary angiotensinogen reflects the activity of intrarenal renin-angiotensin system in patients with IgA nephropathy. Nishiyama, A., Konishi, Y., Ohashi, N., Morikawa, T., Urushihara, M., Maeda, I., Hamada, M., Kishida, M., Hitomi, H., Shirahashi, N., Kobori, H., Imanishi, M. Nephrol. Dial. Transplant. (2011) [Pubmed]
  2. Mineralocorticoid receptor blockade enhances the antiproteinuric effect of an angiotensin II blocker through inhibiting podocyte injury in type 2 diabetic rats. Nishiyama, A., Kobori, H., Konishi, Y., Morikawa, T., Maeda, I., Okumura, M., Kishida, M., Hamada, M., Nagai, Y., Nakagawa, T., Ohashi, N., Nakano, D., Hitomi, H., Imanishi, M. J. Pharmacol. Exp. Ther. (2010) [Pubmed]
  3. New approaches to blockade of the renin-angiotensin-aldosterone system: overview of regulation of the renin-angiotensin-aldosterone system. Nishiyama, A., Kim-Mitsuyama, S. J. Pharmacol. Sci. (2010) [Pubmed]
  4. New approaches to blockade of the renin-angiotensin-aldosterone system: mineralocorticoid-receptor blockers exert antihypertensive and renoprotective effects independently of the renin-angiotensin system. Nishiyama, A., Hasegawa, K., Diah, S., Hitomi, H. J. Pharmacol. Sci. (2010) [Pubmed]
  5. Drug discovery for overcoming chronic kidney disease (CKD): pharmacological effects of mineralocorticoid-receptor blockers. Nishiyama, A., Hitomi, H., Rahman, A., Kiyomoto, H. J. Pharmacol. Sci. (2009) [Pubmed]
  6. Angiotensin II type 1A receptor deficiency and longevity. Nishiyama, A., Matsusaka, T., Miyata, T. Nephrol. Dial. Transplant. (2009) [Pubmed]
  7. Strict angiotensin blockade prevents the augmentation of intrarenal angiotensin II and podocyte abnormalities in type 2 diabetic rats with microalbuminuria. Nishiyama, A., Nakagawa, T., Kobori, H., Nagai, Y., Okada, N., Konishi, Y., Morikawa, T., Okumura, M., Meda, I., Kiyomoto, H., Hosomi, N., Mori, T., Ito, S., Imanishi, M. J. Hypertens. (2008) [Pubmed]
  8. Renal interstitial fluid ATP responses to arterial pressure and tubuloglomerular feedback activation during calcium channel blockade. Nishiyama, A., Jackson, K.E., Majid, D.S., Rahman, M., Navar, L.G. Am. J. Physiol. Heart Circ. Physiol. (2006) [Pubmed]
  9. Molecular mechanisms and therapeutic strategies of chronic renal injury: renoprotective effects of aldosterone blockade. Nishiyama, A., Abe, Y. J. Pharmacol. Sci. (2006) [Pubmed]
  10. Involvement of aldosterone and mineralocorticoid receptors in rat mesangial cell proliferation and deformability. Nishiyama, A., Yao, L., Fan, Y., Kyaw, M., Kataoka, N., Hashimoto, K., Nagai, Y., Nakamura, E., Yoshizumi, M., Shokoji, T., Kimura, S., Kiyomoto, H., Tsujioka, K., Kohno, M., Tamaki, T., Kajiya, F., Abe, Y. Hypertension (2005) [Pubmed]
  11. The SOD mimetic tempol ameliorates glomerular injury and reduces mitogen-activated protein kinase activity in Dahl salt-sensitive rats. Nishiyama, A., Yoshizumi, M., Hitomi, H., Kagami, S., Kondo, S., Miyatake, A., Fukunaga, M., Tamaki, T., Kiyomoto, H., Kohno, M., Shokoji, T., Kimura, S., Abe, Y. J. Am. Soc. Nephrol. (2004) [Pubmed]
  12. Possible contributions of reactive oxygen species and mitogen-activated protein kinase to renal injury in aldosterone/salt-induced hypertensive rats. Nishiyama, A., Yao, L., Nagai, Y., Miyata, K., Yoshizumi, M., Kagami, S., Kondo, S., Kiyomoto, H., Shokoji, T., Kimura, S., Kohno, M., Abe, Y. Hypertension (2004) [Pubmed]
  13. Effects of AT1 receptor blockade on renal injury and mitogen-activated protein activity in Dahl salt-sensitive rats. Nishiyama, A., Yoshizumi, M., Rahman, M., Kobori, H., Seth, D.M., Miyatake, A., Zhang, G.X., Yao, L., Hitomi, H., Shokoji, T., Kiyomoto, H., Kimura, S., Tamaki, T., Kohno, M., Abe, Y. Kidney Int. (2004) [Pubmed]
  14. Aldosterone and renal injury. Nishiyama, A., Abe, Y. Nippon. Yakurigaku. Zasshi (2004) [Pubmed]
  15. Role of interstitial ATP and adenosine in the regulation of renal hemodynamics and microvascular function. Nishiyama, A., Rahman, M., Inscho, E.W. Hypertens. Res. (2004) [Pubmed]
  16. Role of angiotensin II and reactive oxygen species in cyclosporine A-dependent hypertension. Nishiyama, A., Kobori, H., Fukui, T., Zhang, G.X., Yao, L., Rahman, M., Hitomi, H., Kiyomoto, H., Shokoji, T., Kimura, S., Kohno, M., Abe, Y. Hypertension (2003) [Pubmed]
  17. Angiotensin II type 1 receptor-mediated augmentation of renal interstitial fluid angiotensin II in angiotensin II-induced hypertension. Nishiyama, A., Seth, D.M., Navar, L.G. J. Hypertens. (2003) [Pubmed]
  18. Renal interstitial fluid angiotensin I and angiotensin II concentrations during local angiotensin-converting enzyme inhibition. Nishiyama, A., Seth, D.M., Navar, L.G. J. Am. Soc. Nephrol. (2002) [Pubmed]
WikiGenes - Universities